Cullinan Therapeutics Investor Relations Material
Latest events
Status Update
Cullinan Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cullinan Therapeutics Inc
Access all reports
Cullinan Oncology Inc, is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Leveraging a modality-agnostic approach, Cullinan Oncology is dedicated to discovering and developing medicines for high-impact oncology targets. The company's strategy involves rigorous and rapid advancement of highly differentiated molecules, resulting in a robust and diversified pipeline of oncology and immuno-oncology therapies. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Cullinan Therapeutics Inc
Status Update
Cullinan Therapeutics Inc
Status Update
Cullinan Therapeutics Inc
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
CGEM
Country
🇺🇸 United States